Most Americans support Medicare negotiation despite claims it would hurt innovation

3 June 2021 - A new West Health/Gallup survey finds nearly all Democrats (97%) and the majority of Republicans (61%) support ...

Read more →

Making cancer treatments affordable today won’t hurt tomorrow’s innovation

12 May 2021 - Congress is about to debate legislation—the Lower Drug Costs Now Act (H.R.3)—that would give Medicare the ...

Read more →

New analysis shows international reference drug pricing would have a catastrophic impact on Alzheimer's disease research

22 April 2021 - Proposed policy would likely eliminate future clinical development programs in Alzheimer's research, impacting millions of patients and ...

Read more →

NICE launches ambitious strategy to provide quicker access to new treatments and innovations

19 April 2021 - NICE will transform key elements of its approach to ensure efficiency and speed while maintaining robust, trusted ...

Read more →

CBO report shows enacting drug pricing legislation will result in fewer new drugs

12 April 2021 - If there was a silver lining in the COVID-19 pandemic, it was the response of the biopharmaceutical ...

Read more →

NICE methods and process review aims to create fertile ground for innovation

29 March 2021 - The way NICE reviews new medicines is about to go through its biggest change in years – ...

Read more →

Taxpayers fund research and drug companies make a fortune

24 March 2021 - The pharmaceutical industry doesn’t want things to change, but Americans can have both lower prices and innovation. ...

Read more →

It’s time to fast track innovation in medical devices for children

11 February 2021 - When a baby arrived at Children’s National Hospital with a critically underdeveloped heart, it was clear ...

Read more →

Repurposing of prescription medicines

4 February 2021 - The Therapeutic Goods Administration is conducting a public consultation that seeks to understand potential obstacles and ...

Read more →

Funding of pharmaceutical innovation during and after the COVID-19 pandemic

14 January 2021 - The COVID-19 pandemic has highlighted the available mechanisms for funding research, development, manufacturing, and distribution in the ...

Read more →

CDER focuses on novel drug development tools to help speed creation of new therapies

7 December 2020 - There are many novel drug development tools that incorporate the latest advances in science and technology but ...

Read more →

On the integration of early health technology assessment in the innovation process: reflections from five stakeholders

28 October 2020 - Early health technology assessment, which includes all methods used to inform industry and other stakeholders about the ...

Read more →

Health charities and patient groups join together to protect access to breakthrough medical treatments in Canada

19 October 2020 - Patients shut out of process leading to the release of revised guidelines by the Patented Medicine Prices ...

Read more →

Evidence for HTA: innovative methods for challenging times

13 October 2020 - Dalia Dawoud, Scientific Adviser at NICE Science, Evidence and Analytics Directorate explains NICE’s role as co-host of ...

Read more →

Financing drug innovation in the US: current framework and emerging challenges

19 August 2020 - The current US drug innovation financing framework rests on the notion that a defined period of marketing ...

Read more →